Evidence map›Paper›PMID 42132202›Full record

ArticleJournal of the American Heart Association2026

Association of Dietary Patterns and Genetic Risk With Cardiovascular Disease in UK Biobank Cancer Survivors.

Shaojie Han, Zenghui Zhang, Lishan Li, Siqi Gao, Bin Li, Chuxian Guo, Can Lu, Xianwu Lan, Zhaoyu Liu, Jun Guo

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shaojie HanState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Department of Cardiology The First Affiliated Hospital, Jinan University Guangzhou China.
Zenghui ZhangState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Department of Cardiology The First Affiliated Hospital, Jinan University Guangzhou China.ORCID 0009-0003-6245-6847
Lishan LiState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Department of Cardiology The First Affiliated Hospital, Jinan University Guangzhou China.
Siqi GaoState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Department of Cardiology The First Affiliated Hospital, Jinan University Guangzhou China.
Bin LiState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Department of Cardiology The First Affiliated Hospital, Jinan University Guangzhou China.
Chuxian GuoState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Department of Cardiology The First Affiliated Hospital, Jinan University Guangzhou China.
Can LuState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Department of Cardiology The First Affiliated Hospital, Jinan University Guangzhou China.ORCID 0009-0004-1119-6341
Xianwu LanState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Department of Cardiology The First Affiliated Hospital, Jinan University Guangzhou China.
Zhaoyu LiuMedical Research Center, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital Sun Yat-Sen University Guangzhou China.ORCID 0000-0002-2754-8661
Jun GuoState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Department of Cardiology The First Affiliated Hospital, Jinan University Guangzhou China.ORCID 0009-0001-7846-3158

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe extent to which diet influences cardiovascular risk in survivors of cancer is not well established. We therefore assessed how adherence to various dietary patterns relates to the development of cardiovascular disease (CVD) in this population.

methodThis study included 10 414 survivors of cancer from the UK Biobank who were free of CVD and had completed at least two 24-hour dietary recalls. Adherence at baseline to the Alternative Healthy Eating Index 2010 (AHEI-2010), alternate Mediterranean diet, dietary approaches to stop hypertension, and EAT-Lancet diet was examined in relation to incident CVD, and Cox models were used to derive hazard ratios (HRs) with 95% CIs for CVD incidence.

resultsThe mean age of participants was 59.49±7.00 years, and 37% were men in our study. Over a median follow-up of 13.12 years, 1331 incident CVD events were documented. In the fully adjusted model, the HRs for the highest versus lowest tertiles of adherence were 0.83 (95% CI, 0.72-0.97) for alternate Mediterranean diet, 0.76 (95% CI, 0.66-0.87) for AHEI-2010, 0.82 (95% CI, 0.72-0.94) for dietary approaches to stop hypertension, and 0.85 (95% CI, 0.74-0.97) for EAT-Lancet. Specifically, higher adherence to the alternate Mediterranean diet, AHEI-2010, dietary approaches to stop hypertension, and EAT-Lancet diets was associated with lower risks of ischemic heart disease (HR, 0.77-0.85), while the AHEI-2010, dietary approaches to stop hypertension, and EAT-Lancet diets were also linked to reduced risk of heart failure (HR, 0.74-0.88) and the AHEI-2010 and EAT-Lancet diets with lower stroke risk (HR, 0.81-0.83). No significant interaction between the genetic risk of CVD and diet pattern was observed.

conclusionsThese results indicate that following a healthy diet is linked to a reduced risk of CVD among survivors of cancer, regardless of their genetic risk.

Indexed as

Cancer SurvivorsCardiovascular DiseasesDiet, HealthyNeoplasmsRisk Reduction BehaviorAgedBiological Specimen BanksDietary Approaches To Stop HypertensionDiet, MediterraneanFemaleGenetic Predisposition to DiseaseHeart Disease Risk FactorsHumansIncidenceMaleMiddle Agedcancer survivorscardiovascular diseasedietary patterngenetic susceptibility

Identifiers

PMID42132202
PMCPMC13279647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.